Ardelyx Shares Down ~17% This Week; Co. Collab Partner, Kyowa Kirin, On Monday Morning Announced Phase 3 Results Of Tenapanor For Hyperphosphatemia In Patients On Hemodialysis In Japan; Ardelyx Shares Appeared Unaffected